These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30814375)

  • 41. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Regulation of Bone Metabolism and Disorders by Wnt Signaling.
    Maeda K; Kobayashi Y; Koide M; Uehara S; Okamoto M; Ishihara A; Kayama T; Saito M; Marumo K
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The canonical way to make a heart: β-catenin and plakoglobin in heart development and remodeling.
    Piven OO; Winata CL
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1735-1745. PubMed ID: 28920469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
    Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
    J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway.
    Pan L; Shi X; Liu S; Guo X; Zhao M; Cai R; Sun G
    Toxicol Lett; 2014 Feb; 225(1):34-42. PubMed ID: 24300170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sclerostin vaccination mitigates estrogen deficiency induction of bone mass loss and microstructure deterioration.
    Wang FS; Wu RW; Lain WS; Tsai TC; Chen YS; Sun YC; Ke HJ; Li JC; Hwang J; Ko JY
    Bone; 2018 Jul; 112():24-34. PubMed ID: 29653294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.
    Lin C; Jiang X; Dai Z; Guo X; Weng T; Wang J; Li Y; Feng G; Gao X; He L
    J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antagonists of Wnt pathway].
    Kinoshita Y; Fukumoto S
    Clin Calcium; 2013 Jun; 23(6):817-23. PubMed ID: 23719493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Bone and Nutrition. Sclerostin and bone metabolism].
    Tatsumi S; Nagamoto K; Ogata M; Miyamoto K
    Clin Calcium; 2015 Jul; 25(7):1043-7. PubMed ID: 26119318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways.
    Bouaziz W; Funck-Brentano T; Lin H; Marty C; Ea HK; Hay E; Cohen-Solal M
    Arthritis Res Ther; 2015 Feb; 17(1):24. PubMed ID: 25656376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation.
    Lee JW; Asai M; Jeon SK; Iimura T; Yonezawa T; Cha BY; Woo JT; Yamaguchi A
    Mol Nutr Food Res; 2015 Mar; 59(3):386-400. PubMed ID: 25380345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sclerostin and DKK1: new players in renal bone and vascular disease.
    Evenepoel P; D'Haese P; Brandenburg V
    Kidney Int; 2015 Aug; 88(2):235-40. PubMed ID: 26083653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomolecular Cell-Signaling Mechanisms and Dental Implants: A Review on the Regulatory Molecular Biologic Patterns Under Functional and Immediate Loading.
    Romanos GE
    Int J Oral Maxillofac Implants; 2016; 31(4):939-51. PubMed ID: 27447163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β-catenin signaling pathway.
    Zhang W; Wang S; Yin H; Chen E; Xue D; Zheng Q; Gao X; Pan Z
    Fundam Clin Pharmacol; 2016 Dec; 30(6):596-606. PubMed ID: 27469984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
    Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
    Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wnt signaling and osteoblastogenesis.
    Bodine PV; Komm BS
    Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Osteocytes and Wnt signaling.].
    Fukumoto S
    Clin Calcium; 2019; 29(3):317-321. PubMed ID: 30814376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling.
    Wang C; Yue Y; Shao B; Qiu Z; Mu J; Tang J; Han X; Xiang T; Ren G
    Cell Physiol Biochem; 2017; 41(5):1709-1724. PubMed ID: 28365691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acceleration of bone regeneration by local application of lithium: Wnt signal-mediated osteoblastogenesis and Wnt signal-independent suppression of osteoclastogenesis.
    Arioka M; Takahashi-Yanaga F; Sasaki M; Yoshihara T; Morimoto S; Hirata M; Mori Y; Sasaguri T
    Biochem Pharmacol; 2014 Aug; 90(4):397-405. PubMed ID: 24955980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.